An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence
Fecal incontinence (FI) is the involuntary loss of rectal contents through the anal canal. Reports of its prevalence vary from 1–21%. Studies, have demonstrated a positive effect on FI symptoms with injectable bulking agents. This study evaluated the safety and efficacy of NASHA/Dx gel in the treatm...
Saved in:
| Main Authors: | Giuseppe Dodi, Johannes Jongen, Fernando de la Portilla, Manoj Raval, Donato F. Altomare, Paul-Antoine Lehur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2010/467136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEMEROLEHAN PRAGMATIK PADA ANAK USIA TIGA TAHUN: STUDI KASUS PADA NASHA
by: Karis Cindiana, et al.
Published: (2025-03-01) -
Research progress of neuroregulation in the treatment of fecal incontinence
by: Liu Jin, et al.
Published: (2024-10-01) -
Investigating and Treating Fecal Incontinence: When and How
by: Adriana Lazarescu, et al.
Published: (2009-01-01) -
A Systematic Review of Fecal Incontinence after Hysterectomy
by: Madison M. Patrick, et al.
Published: (2025-04-01) -
Is It a Refractory Disease?- Fecal Incontinence; beyond
Medication
by: Chungyeop Lee, et al.
Published: (2022-10-01)